Child diagnoses are rising; however, due to changing definitions, systems, and expectations, it is not an epidemic of illness ...

CompanyOverview|NASDAQ:CLLS] Cellectis S.A. (NASDAQ: CLLS) is a clinical-stage biotechnology company focused on developing ...

Three specialties broke away from the pack with the highest projected growth rates through 2033, according to May 2024 data from the U.S. Bureau of Labor Statistics, published April 2. The specialties ...

Startup Brellium built an artificial intelligence-powered solution that helps providers automate clinical quality and payer ...

Seattle Children’s created a clinical effectiveness program under its center of quality to look up all medical literature available for tough questions. The program includes millions of pieces of ...

The investment risks with marijuana stocks are considerable despite the high growth potential. Key findings are powered by ChatGPT and based solely off the content from this article. Findings are ...

A clinical trial conducted in a neonatal intensive care unit has identified a new treatment protocol to improve lung growth and function among preterm infants.

BayCare Health System recently finalized its $4 billion disaffiliation from Trinity Health, ushering in what executives are calling “BayCare 2.0” — a new era of local governance, strategic agility and ...

Veeva Systems is overvalued, with modest ~10% growth & high valuation multiples. Read why I recommend a sell rating on VEEV ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

OSI Systems has key strategies that can drive long-term revenue and earnings growth. Learn why OSIS stock is a Buy.

Seasoned clinical and medical experts join to propel potential first ... These strategic hires will support the company’s ambitious growth trajectory and drive operational excellence. “I am delighted ...